These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

612 related items for PubMed ID: 28070704

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Predictors of nonresponse to lactulose for minimal hepatic encephalopathy in patients with cirrhosis.
    Sharma P, Sharma BC, Sarin SK.
    Liver Int; 2009 Oct; 29(9):1365-71. PubMed ID: 19555401
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
    Singh J, Sharma BC, Maharshi S, Puri V, Srivastava S.
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1203-9. PubMed ID: 26716736
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lactulose for minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.
    Sharma P, Sharma BC.
    Saudi J Gastroenterol; 2012 Jun; 18(3):168-72. PubMed ID: 22626795
    [Abstract] [Full Text] [Related]

  • 8. Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy.
    Sidhu SS, Goyal O, Parker RA, Kishore H, Sood A.
    Liver Int; 2016 Mar; 36(3):378-85. PubMed ID: 26201713
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy.
    Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R.
    Hepatology; 2007 Mar; 45(3):549-59. PubMed ID: 17326150
    [Abstract] [Full Text] [Related]

  • 14. Lactulose reduces bacterial DNA translocation, which worsens neurocognitive shape in cirrhotic patients with minimal hepatic encephalopathy.
    Moratalla A, Ampuero J, Bellot P, Gallego-Durán R, Zapater P, Roger M, Figueruela B, Martínez-Moreno B, González-Navajas JM, Such J, Romero-Gómez M, Francés R.
    Liver Int; 2017 Feb; 37(2):212-223. PubMed ID: 27388776
    [Abstract] [Full Text] [Related]

  • 15. Night-time sleep disturbance does not correlate with neuropsychiatric impairment in patients with cirrhosis.
    Montagnese S, Middleton B, Skene DJ, Morgan MY.
    Liver Int; 2009 Oct; 29(9):1372-82. PubMed ID: 19686311
    [Abstract] [Full Text] [Related]

  • 16. Critical flicker frequency test for diagnosing minimal hepatic encephalopathy in patients with cirrhosis.
    Özel Coşkun BD, Özen M.
    Turk J Gastroenterol; 2017 May; 28(3):191-196. PubMed ID: 28316320
    [Abstract] [Full Text] [Related]

  • 17. Secondary prophylaxis of hepatic encephalopathy in cirrhosis: an open-label, randomized controlled trial of lactulose, probiotics, and no therapy.
    Agrawal A, Sharma BC, Sharma P, Sarin SK.
    Am J Gastroenterol; 2012 Jul; 107(7):1043-50. PubMed ID: 22710579
    [Abstract] [Full Text] [Related]

  • 18. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
    Ampuero J, Simón M, Montoliú C, Jover R, Serra MÁ, Córdoba J, Romero-Gómez M.
    Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
    [Abstract] [Full Text] [Related]

  • 19. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
    Sharma P, Sharma BC, Agrawal A, Sarin SK.
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
    [Abstract] [Full Text] [Related]

  • 20. Nutritional therapy for persistent cognitive impairment after resolution of overt hepatic encephalopathy in patients with cirrhosis: A double-blind randomized controlled trial.
    Sharma BC, Maharshi S, Sachdeva S, Mahajan B, Sharma A, Bara S, Srivastava S, Kumar A, Dalal A, Sonika U.
    J Gastroenterol Hepatol; 2023 Nov; 38(11):1917-1925. PubMed ID: 37354045
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.